Vitamin B3 Shows Promise in Treating Fatty Liver Disease
South Korean researchers discover vitamin B3 can treat fatty liver disease by targeting genetic driver microRNA-93, offering hope for 30% of global population.
In a remarkable convergence of cutting-edge genetics and everyday nutrition, South Korean researchers have identified a simple vitamin that could revolutionise treatment for fatty liver disease. Their study, published this week, reveals that vitamin B3 (niacin) - available in any pharmacy for pennies - can effectively suppress microRNA-93, a key genetic driver of metabolic associated steatotic liver disease (MASLD).
This discovery is particularly significant because MASLD affects roughly 30% of people worldwide, making it one of the most common liver conditions globally. Unlike many medical breakthroughs that require years of development and astronomical costs, this solution is already FDA-approved, widely available, and costs under £10 per month.
The research team used advanced genomic analysis to pinpoint microRNA-93 as a crucial factor in how the liver processes fats. When this microRNA is overactive, it triggers the fat accumulation that characterises MASLD. Vitamin B3, they discovered, can dial down this genetic switch, allowing the liver to return to normal function.
What makes this finding extraordinary is its immediate actionability. While most research discoveries require a decade or more to reach patients, this treatment could theoretically be implemented tomorrow. The vitamin's established safety profile means doctors could consider prescribing it off-label while formal clinical trials proceed.
Key Facts
- MASLD affects approximately 30% of the global population (2.4 billion people)
- Vitamin B3 supplements typically cost £5-15 per month
- The vitamin is already FDA-approved with a well-established safety profile
- MicroRNA-93 was identified as the key genetic target through genomic analysis
- Study conducted at leading South Korean research institution
Why This Matters
This development represents a significant step forward in addressing global health and sustainability challenges, offering hope for millions of people worldwide.
What We Don't Know Yet
While these findings are promising, further research is needed to confirm long-term effects and optimal implementation strategies. Patients should consult healthcare professionals before making any treatment decisions based on these early results.